‘Build Not Your Nest Here’: Learning Suffering from the Puritans

The English Puritans and their Scottish counterparts, the Covenanters, experienced intense suffering. Along with their contemporaries, they faced the normal hardships of the seventeenth-century world: plagues, illnesses, and the deaths of infants, children, and women in childbirth. In addition to these, however, many of the Puritans endured deep and persistent persecution. The Stuart monarchs (1603–1685)…

Read More

Idorsia Urges DEA to De-schedule DORA Class of Insomnia Medications

Idorsia Pharmaceuticals filed a Citizen Petition with the Drug Enforcement Administration (DEA), urging them to de-schedule the dual orexin receptor antagonist (DORA) class of chronic insomnia medications based on data indicating a low potential for abuse. The petition outlines scientific and medical evidence demonstrating that the DORA class has a negligible abuse profile and potential…

Read More

Zevra Seeks FDA Authorization to Investigate KP1077 for Narcolepsy

Zevra Therapeutics Inc, formerly KemPharm, announced the submission of an Investigational New Drug application, seeking authorization from the US Food and Drug Administration (FDA) to begin a phase 1 clinical trial of KP1077 in narcolepsy.  Once the clinical investigation plan proposed in the Investigational New Drug application has been cleared to proceed by the FDA,…

Read More

Self-Applied Wireless Home Polysomnography Solution Set to Roll Out

Onera Health announced a strategic partnership with MedBridge Healthcare to deliver Onera’s self-applied, no-wire home polysomnography solution to people struggling with sleep disorders in the US. The new partnership aims to broaden access to Onera’s medical-grade polysomnography-as-a-service solution, improving the patient experience and lowering the operational burden currently faced in many sleep clinics across the…

Read More